Brian Tenney, who owned the now-shuttered West Coast Game Park Safari in Bandon, was sentenced Tuesday afternoon to seven ...

New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of ...

A failure to perform a primary obligation under a contract is a breach, which gives rise to a secondary obligation on the ...

Holmes is back in the spotlight as the subject of a new A24 documentary from Nathan Fielder and “Primetime” director Lance ...

The Japanese yen's turmoil threatened to hit Americans with higher prices for mortgages, investments and borrowing costs, as ...

The "Epidermolysis Bullosa - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The epidermolysis bullosa market is entering a period of ...

NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.

Conventional medical treatment of both acute and recurrent herpes infections focuses on drug therapy. The two most common ...

NanoViricides announces Phase II clinical trial for oral Ebola drug NV-387 registered in Pan African database, ready to treat patients amid growing DRC outbreak.

(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment ...

DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of innovative point-of-care eye diagnostic solutions, is pleased to announce the submission of a ...